Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

Cell

Volumn 90, Issue 3, 1997, Pages 537-548

  Davies, Stephen W ^a   Turmaine, Mark ^a   Cozens, Barbara A ^a   DiFiglia, Marian ^b   Sharp, Alan H ^c   Ross, Christopher A ^c   Scherzinger, Eberhard ^d   Wanker, Erich E ^d   Mangiarini, Laura ^e   Bates, Gillian P ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BASAL GANGLION; CELL DEATH; CELL DENSITY; CELL INCLUSION; GENE MUTATION; GLIOSIS; HUNTINGTON CHOREA; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT; TRANSGENE;

ANIMALIA; MUS MUSCULUS;

EID: 18544410106     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80513-9     Document Type: Article

References (55)

1. Alzheimer, A. (1911). Über die anatomische Grundlage der Huntingtonschen chorea und der choreatischen Bewegungen überhaupt. Z. Ges. Neurol. Psychiat. 3, 566-567.
2. Aronin, N., Chase, K., Young, C., Sapp, E., Schwarz, C., Matta, N., Kornreich, R., Landwehrmeyer, B., Bird, E., Beal, M.F., et al. (1995). CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain. Neuron 15, 1193-1201.
3. Bates, G.P., Mangiarini, L., Mahal, A., and Davies, S.W. (1997). Transgenic models of Huntingtons disease. Hum. Mol. Genet., in press.
4. Bhide, P., Day, M., Sapp, E., Schwarz, C., Sheth, A., Kim, J., Young, A.B., Penney, J., Golden, J., Aronin, N., and DiFiglia, M. (1996). Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 16, 5523-5535.
5. Bots, G. Th.A.M., and Bruyn G.W. (1987). Neuropathological changes of the nucleus accumbens in Huntingtons chorea. Acta Neuropathol. 55, 21-22.
6. Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A., Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price, D.L., and Cleveland, D.W. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338.
7. Burke, J.R., Enghild, J.J., Martin, M.E., Jou, Y.-S., Myers, R.M., Roses, A.D., Vance, J.M., and Strittmatter, W.J. (1996). Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2, 347-350.
8. Burright, E.N., Clark, H.B., Servadio, A., Matilla, T., Fedderson, R.M., Yunis, W.S., Duvick, L.A., Zoghbi, H.Y., and Orr, H.T. (1995). SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937-948.
9. de la Monte, S.M., Vonsattel, J.-P., and Richardson, E.P. (1988). Morphometric demonstration of atrophic changes in the cerebral cortex, white matter and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 47, 516-525.
10. De Rooij, K.E., Dorsman, J.C., Smoor, M.A., Den Dunnen, J.T. and Van Ommen, G.-J.B. (1996). Subcellular localization of the Huntingtons disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet. 5, 1093-1099.
11. DiFiglia, M., Sapp, E., Chase, K., Schwarcz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S.A., Boyce, F.M., et al. (1995). Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
12. Duyao, M.P., Auerbach, A.A., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonstattel, J.-P., Gusella, J.F., Joyner, A.L., and MacDonald, M.E. (1995). Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407-410.
13. Ebling, F.J.P., Maywood, E.S., Mehta, M., Hancock, D.C., Me Nulty, S., De Bono, J., Bray, S.J., and Hastings, M.H. (1996). Fos B in the surrachiasmatic nucleus of the Syrian and Siberian hamster. Brain Res. Bull. 41, 257-268.
14. Forno, L.S., and Norville R.L. (1979). Ultrastructure of the neostriatum in Huntingtons and Parkinsons disease. In Advances in Neurology 23, Huntingtons Disease, T.N. Chase, N.S. Wexler, and A. Barbeau, eds. (New York: Raven Press), pp. 95-122.
15. Goedert, M., Spillantini, M.G., Cairns, N.J., and Crowther, R.A. (1992). Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
16. Goldberg, Y.P., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, H.B., Graham, R.K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N.A., Vaillancourt, J.P., and Hayden, M.R. (1996). Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442-449.
17. Graveland, G.A., Williams, R.S., and DiFiglia, M. (1985). Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntingtons disease. Science 227, 770-773.
18. Gutekunst, C.A., Levey, A.I., Heilman, D.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J., and Hersch, S.M. (1995). Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusionprotein antibodies. Proc. Nat. Acad. Sci. USA 92, 8710-8714.
19. Harper, P.S. (1991). Huntingtons Disease, Major Problems in Neurology 22 (London: W.B. Saunders).
20. Hedreen, J.C., and Folstein, S.E. (1995). Early loss of neostriatal neurons in Huntingtons disease. J. Neuropathol. Exp. Neurol. 54, 105-120.
21. Hollen, K.M., Nakabeppu, Y., and Davies, S.W. (1997). Changes in the expression of ΔFos B and the Fos family proteins following NMDA receptor activation in the rat srtiatum. Mol. Brain Res. 47, 31-43.
22. Huntingtons Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is unstable on Huntingtons disease chromosomes. Cell 72, 971-983.
23. Ide, K., Nukina, N., Masuda, N., Goto, J., and Kanazawa, I. (1995). Abnormal gene product identified in Huntington's disease lymphocytes and brain. Biochem. Biophys. Res. Comm. 209, 1119-1125.
24. Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S., and Kakizuka, A. (1996). Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196-202.
25. Jou, Y.-S., and Myers, R.M. (1995). Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465-469.
26. Kalchman, M.A., Graham, R.K., Xia, G., Koide, H.B., Hodgson, J.G., Graham, K.C., Goldberg, Y.P., Gietz, R.D., Pickart, C.M., and Hayden, M.R. (1996). Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J. Biol. Chem. 32, 19385-19394.
27. Kemp, J.M., and Powell, T.P.S. (1971). The structure of the caudate nucleus of the cat: light and electron microscopy. Philos. Trans. R. Soc. Lond. [Biol] 262, 383-401.
28. Kosinski, C.M., Cha, J.-H., Young, A.B., Persichetti, F., MacDonald, M., Gusella, J.F., Penney, J.B., and Standaert, D.G. (1997). Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurones. Exp. Neurol., in press.
29. Kowall, N.W., Ferrante, R.J., and Martin, J.B. (1987). Patterns of cell loss in Huntingtons disease. Trends Neurosci. 10, 24-29.
30. Li, X.-J., Li, S.-H., Sharp, A.M., Nucifora, F.C., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H., and Ross, C.A. (1995). A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
31. Lieberman, A.R. (1971). A review of the principal features of perikaryal responses to axon injury. Int. Rev. Neurobiol. 14, 49-124.
32. Liu, Q., and Dreyfuss, G. (1996). A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15, 3555-3565.
33. Lowe, J., Aldridge, F., Lennox, G., Doherty, F., Jefferson, D., Landon M., et al. (1989). Inclusion bodies in motor cortex and brainstem of patients with motor neurone disease are detected by immunocytochemical localization of ubiquitin. Neurosci. Lett. 105, 7-13.
34. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W., and Bates, G.P. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
35. Mangiarini, L., Sathasivam, K., Mahal, A., Mott, R., Seller, M. and Bates, G.P. (1997). Instability of highly expanded CAG repeats in mice transgenic for the Huntingtons disease mutation. Nature Genet. 15, 197-200.
36. Myers, R.H., Vonsattel, J.P., Stevens, T.J., Cupples, L.A., Richardson, E.P., Martin, J.B., and Bird, E.D. (1988). Clinical and neuropathological assessment of severity in Huntington's disease. Neurology 38, 341-347.
37. Myers, R.H., Vonsattel, J.P., Paskevich, P.A., Kiely, D.K., Stevens, T.J., Cupples, L.A., Richardson, E.P., and Bird, E.D. (1991). Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J. Neuropathol. Exp. Neurol. 50, 729-742.
38. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G., and Hayden, M.R. (1995). Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
39. Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D., Fischbeck, K.H., and Pittman, R.N. (1997). Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann. Neurol. 41, 453-462.
40. Perutz, M.F. (1996). Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr. Opin. Struct. Biol. 6, 848-858.
41. Peters, A., Palay, S.L., and Webster, H.deF. (1991). The Fine Structure of the Nervous System. (New York: Oxford University Press).
42. Roizin, L., Stellar, S., and Liu, J.C. (1979). Neuronal nuclear-cytoplasmic changes in Huntingtons chorea: electron microscope investigations. In Advances in Neurology 23, Huntingtons Disease, T.N. Chase, N.S. Wexler, and A. Barbeau, eds. (New York: Raven Press), pp. 95-122.
43. Roos, R.A.C., and Bots, G.Th.A.M. (1983). Nuclear membrane indentations in Huntingtons chorea. J. Neurol. Sci. 61, 37-47.
44. Ross, C.A. (1995). When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15, 493-496.
45. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G.P., Davies, S.W., and Wanker, E.E. (1997). Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell, this issue, 90, 549-558.
46. Schilling, G., Sharp, A.M., Loev, S.J., Wagster, M.V., Li, S.-H., Stine, O.C., and Ross, C.A. (1995). Expression of the Huntington's disease (IT15) protein product in HD patients. Hum. Mol. Genet. 4, 1365-1371.
47. Sharp, A.H., Loev, S.J., Schilling, G., Li, S.-H., Li X.-J., Bao, J., Wagster, M.V., Kotzuk, J.A., Steiner, J.P., Lo, A., et al. (1995). Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074.
48. Spillantini, M.G., Goedert, M., Jakes, R., and Klug, A. (1990). Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease. Proc. Natl. Acad. Sci. USA 87, 3952-3956.
49. Tellez-Nagel, I., Johnson B., and Terry, R.D. (1974). Studies on brain biopsies of patients with Huntingtons chorea. J. Neurocytol. 3, 308-332.
50. Trottier, Y., Devys, D., Imbert, G., Sandou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.C., and Mandel, J.-L.(1995a). Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated forms. Nature Genet. 10, 104-110.
51. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Sandou, F., Weber, C., David, G., Tora, L., et al. (1995b). Polyglutamine expansion as a pathological epitope in Huntingtons disease and four dominant cerebellar ataxias. Nature 378, 403-406.
52. Vonsattel, J.-P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., and Richardson, E.P. (1985). Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
53. Wanker, E.E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J., and Lehrach, H. (1997). HIP-1: a huntingtin interacting protein isolated by the yeast two-hybrid system. Human Mol. Genet. 6, 487-495.
54. Wisden, W., Errington, M.L., Williams, S., Dunnett, S.B., Waters, C., Hancock, D., Evan, G., Bliss, T.V., and Hunt, S.P. (1990). Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron 4, 603-614.
55. Zeitlin, S., Liu, J.-P., Chapman, D.L., Papaioannou, V.E., and Estradiatis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11, 155-163.